Tony J. Wu

Tony J. Wu

Auto-generated profile, based on publicly available information

Tony J. Wu

Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2016 in Cell
Verified
Journal Article
Closed access
JBJoseph L. Benci
Joseph L. Benci
BXBihui Xu
Bihui Xu
YQYu Qiu
Yu Qiu
TWTony J. Wu
Tony J. Wu
HDHannah Dada
Hannah Dada
AMAndy J. Minn
Andy J. Minn

1 July 2017 in Cell
Verified
Journal Article
Closed access
BNBarzin Y. Nabet
Barzin Y. Nabet
YQYu Qiu
Yu Qiu
JSJacob E. Shabason
Jacob E. Shabason
TWTony J. Wu
Tony J. Wu
TYTaewon Yoon
Taewon Yoon
AMAndy J. Minn
Andy J. Minn

28 July 2016 in Cancer Research
Verified
Journal Article
Closed access
TWTony J. Wu
Tony J. Wu
BNBarzin Y. Nabet
Barzin Y. Nabet
BXBihui Xu
Bihui Xu
MBMirjam C. Boelens
Mirjam C. Boelens
JJJos Jonkers
Jos Jonkers
AMAndy J. Minn
Andy J. Minn
Breast cancer cells can achieve protection from DNA damage both through cell-autonomous mechanisms and intercellular communication with the tumor microenvironment. Previously, we described an Interferon-Related DNA Damage Resistance Signature comprising of a network of interferon-stimulated genes (ISGs) that promotes and clinically predicts chemotherapy and radiation resistance in breast cancer. Here, we examine the heterotypic tumor-stroma interactions that regulate ISGs. We show that STAT1 and other ISGs are induced in breast cancer cells following interaction with stroma. STAT1 induces NOTCH3 expression, explaining a requirement for juxtacrine signaling. Moreover, we report that stroma upregulates ISG expression in breast cancer cells through exosomes. Exosomes transferred from the stroma and ISG induction are both dependent on RAB27B. In mice, targeting these pathways abrogate stroma-mediated resistance and results in long-term tumor-free survival. Analysis of primary human tumors supports the role of anti-viral/NOTCH3 pathways in NOTCH signaling and stroma-mediated resistance. To determine whether these observations can further predict clinical efficacy, cell lines derived from a genetically engineered mouse model for p53-induced breast cancer, K14cre;Brca1F/F;p53F/F, were tested. We show that stroma induces breast cancer ISGs through exosomes, which in turn can induce signaling to activate NOTCH3 and regulate DNA damage resistance. Citation Format: Tony J. Wu, Barzin Y. Nabet, Bihui Xu, Mirjam C. Boelens, Jos Jonkers, Andy J. Minn. Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways in triple-negative breast cancer. [abstract]. In: Proceedings of the AACR Special Conference: Function of Tumor Microenvironment in Cancer Progression; 2016 Jan 7–10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2016;76(15 Suppl):Abstract nr A45.